info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Anesthesia Drugs Market Global Report, Size 2021 -2030

Anesthesia Drugs Market By Type (General Anesthesia Drug, Local Anesthesia Drug), Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Others), Route Of Administration (Inhalation, Intravenous, Others), By Geography, Segment revenue estimation, Forecast: 2021-2030

Published On: Nov-2021   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 28818994

Report DescriptionTable of Contents

Industry Report and Statistics

The global anesthesia drugs market will witness a robust CAGR of 3.47%, valued at $7.03 billion in 2021, expected to appreciate and reach $9.56 billion by 2030, confirms Strategic Market Research. Anesthesia can be described as a state of temporary unconsciousness, loss of pain perception, memory loss, and muscle relaxation. Most people associate the word Anesthesia with medically induced unconsciousness before surgery. Apart from the fact that Anesthesia may be a relief for those who want to avoid surgical pain, its risks can also be a concern for those who fear medically induced unconsciousness. According to statistics from 2014, the death rate due to Anesthesia (although performed by Anaesthesiologists) during surgical procedures stayed steady at three per 10,000. Between the years 2010 and 2013, the rate of complications decreased to 4.65% from 11.84%. Nausea and vomiting were the most common minor side effects of Anesthesia. In 3.2 million cases of Anesthesia administered during this period, this issue was reported in 36% of the cases.

Anesthesia Drugs Market by Type Image

Nearly 12% of cases reported medication errors (Anesthesia Overdose/Underdose) as the most common major complication. The following conditions increase the risk of Anesthesia complications: smoking, obstructive sleep apnea, high blood pressure, obesity, diabetes, heart or lung ailments, alcoholism or Drug allergies, or any history of Anesthesia complications. There will be a greater need for Anesthesia Drugs over the next decade as the elderly population is growing at a rapid pace hence more people will require medical care. Subsequently, it will give a boost to Anesthesia Drug’s market share.

 

Significance of Anaesthetic Drugs in the Pharmaceutical Market: - Anesthesia is a medication that prevents you from feeling pain during surgical procedures. Anaesthetics are medications that vandalize pain and help patients to relax during surgical procedures. Anesthesia has various varieties and forms like General Anesthesia Drugs, regional Anesthesia, Epidural, Spinal Anesthesia, and Nerve Block Anesthesia Drugs, Combined General and Epidural Anesthesia.  Each type of Anesthesia prevents different pain sensations. Some anaesthetics can numb certain parts of the body, while other medicines can numb the brain, thereby causing sleep during more invasive surgeries, such as those that take place in the abdomen, head, or chest.

 

Impact of Covid 19 on the Global Anesthesia Drugs Market: -

A slight decline in the demand for Anesthesia Drugs was observed in 2020 as a result of the pandemic, causing delays or cancellations of surgeries. According to a study published in the British Journal of Surgery, approximately 28.4 million elective surgeries were cancelled or postponed globally in May 2020 due to the disruption of hospital services caused by COVID-19. Nevertheless, as social activities are resuming, all elective surgeries that were delayed, are being performed now, which means that Anesthesia Drugs are being consumed in greater quantities resulting in the Anesthesia Drugs market gradually picking up market growth.

 

Market Dynamics: Driver, Restraints, Opportunity and Challenges

Market Drivers and Opportunities: Increasing number of surgeries, a growing elderly population and advances in technology poised to boost the growth of the market

One of the major factors driving the anaesthetics market is the increase in the number of surgeries performed, that use anaesthetics during the surgical procedure. An increase in surgeries is primarily due to the increasing incidents of traumatic injuries and accidents requiring surgical procedures. World Health Organization's Global status report on road safety 2018 shows that there are 1.35 million road accidents every year, with 64 deaths per 100,000 vehicles. Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patients' physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are the driving factors that will boost the market growth. By 2050, one out of four people living in Europe and Northern America could be 65 years or older, according to the Department of Economic and Social Affairs of the United Nations. With an increase in the elderly population, chronic diseases such as cardiovascular and neurological are on the rise in older populations, further increasing the need for anesthesia drugs. As of June 15, 2019, Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, which is used to sedate non-intubated patients before and/or during surgery, is available from Fresenius Kabi. Due to this, the market for Global Anesthesia Drugs is expected to grow.

 

Market Restraint: Lack of Infrastructure, Lack of Awareness and High cost of Drugs and procedures restraining the growth of the market

An expected restraint in the growth of the Anesthesia Drugs market is due to the lack of healthcare facilities in underdeveloped countries and remote areas, as well as the lack of Anesthesia doctors and certified Anesthesia nurses per capita. Additionally, during the forecast period, high prices of procedures and branded Drugs will hinder the growth of this market. Lack of Anesthesia awareness among the common masses is also a condition that negatively affects the Anesthesia Drugs market.

 

Market Challenges: Unintentional intraoperative awareness is one of the major challenges to the Anesthesia market

Moreover, during the surgical process when general Anesthesia is given, approximately one or two people out of every 1000 may be unaware that they are partially awake. There is very little chance of experiencing pain, but this can also occur.  Since people are being given relaxation Drugs before surgeries, they cannot move or communicate their pain or awareness to the doctors. There is the possibility that this will cause patients long-term psychological problems, similar to post-traumatic stress disorder. This is called unintentional intraoperative awareness and it is one of the major challenges to the Anesthesia market.

 

Market Analysis Of Different Segments Covered in the Report

We have segmented the Global Anesthesia Drugs Market into:

  • Type 

  • Application 

  • Route Of Administration 

  • Regional

 

By Type, the Global Anesthesia Drugs Market has been classified into:

  • General Anesthesia Drugs

  • Local Anesthesia Drugs

 

General Anesthesia Drugs dominated the market owing to the increasing number of major surgeries around the world since they helped doctors to create individualized anaesthetic plans that balance the patient's history with the anticipated surgical plan that maximizes patient safety. Local Anesthesia Drugs, on the other hand, is growing at the fastest CAGR rate since it is considered safer than general Anesthesia due to the absence of systemic side effects.

 

Anesthesia Drugs Market By Route of Administration

 

By Application, the Global Anesthesia Drugs Market has been classified into:

  • General Surgeries

  • Plastic Surgery

  • Cosmetic Surgeries

  • Dental Surgeries

  • Other Surgeries

 

General Surgery dominated the market as anaesthetics are widely used in these surgical procedures. The market is expected to grow significantly over the forecasted period. The market is being driven by the growing number of surgeries, the ageing population with an increasing number of chronic diseases as well as technological advancements in Anesthesia. On the other hand, in 2019, nearly 1.8 million cosmetic surgical procedures were completed in the United States and 16.3 million cosmetic minimally-invasive procedures were performed, according to statistics from the American Society of Plastic Surgeons (ASPS).

 

By Route of Administration, the Global Anesthesia Drugs Market has been classified into:

  • Inhalation

  • Intravenous

  • Others

 

Intravenous Drugs dominated the Anesthesia Drugs market as it offers various advantages such as more accurate dose delivery, better patient safety, lower rates of (postoperative nausea, vomiting, urinary retention, and malignant hyperthermia (a rare but serious side effect of general Anesthesia)), reduced risk of blood clots and pulmonary emboli (blood clots that move to the lungs).

 

Regional Analysis: North America is witnessing a demand for Anesthesia Drugs due to the increasing number of surgeries in the region.

The Anesthesia Drugs Market report includes Asia Pacific, North America, Europe and LAMEA. North America is witnessing a huge surge in surgical procedures each year. In this region, ailments like cancer, heart disease, and cardiovascular disease are highly prevalent and increasing at a rapid pace. There are a plethora of growth opportunities in this market due to the prevalence of these surgeries. Forecasts for the US Anesthesia Drugs market indicate a robust upsurge which will attribute to the growth of the North America Anesthesia Drugs market. Moreover, the Asia Pacific region is projected to grow at the highest rate due to its rapidly expanding healthcare infrastructure and the presence of major players. The adoption of Anesthesia Drugs is increasing rapidly in this region which will drive high revenue growth among these regional players.

 

Anesthesia Drugs Market By Region

 

The report covers the following segments:

Global, regional, and country-wise revenue growth is forecasted in the report between 2021 to 2028. This report divides the Global Anesthesia Drugs market into:

By Type

  • General Anaesthetics

    • Propofol

    • Sevoflurane

    • Desflurane

    • Dexmedetomidine

    • Remifentanil

    • Midazolam

  • Local Anaesthetics

    • Bupivacaine

    • Ropivacaine

    • Lidocaine

    • Chloroprocaine

    • Articaine

    • Benzocaine

 

By Application

  • General Surgeries

  • Plastic Surgery

  • Cosmetic Surgeries

  • Dental Surgeries

 

By Route Of Administration

  • Inhalation Anesthesia Drugs

  • Intravenous Anesthesia Drugs

  • Topical Anesthesia Drugs

 

Anesthesia Drugs Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

Market size value in 2021

USD 7.03 billion

Revenue forecast in 2030

USD 9.56 billion

Growth rate

CAGR of approximately 3.47%

Base year for estimation

2021

Historical data

2015 – 2019

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Type, By Application, By Route Of, Administration, By   Region

By Type

General Anesthesia Drugs, Local Anesthesia Drugs

By Application

General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental   Surgeries, Others

By Route Of Administration

Inhalation, Intravenous, Others

By Region

Asia Pacific, North America, Europe, LAMEA

Country Scope

U.S., Canada, France, Germany, U.K., China, Japan, India,  South Korea,  Mexico, Brazil, U.A.E. etc.

Company Usability Profiles

Charles River Laboratories International, Inc., The Jackson   Laboratory, Laboratory Corporation of America Holdings   (Covance), Perkin Elmer (Horizon Discovery Group plc),   genOway, Envigo, JANVIER LABS, Taconic Biosciences Inc.,   Biomedical Research Models (Biomere), Transpogen  Biopharmaceutical, Inc.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

 

Anesthesia Drugs Market Competitive Landscape Analysis

The market report explores the recent significant developments by leading vendors, along with their in-depth company profiles, the key players included in the report are:

  • Abbott Laboratories 

  • AbbVie Inc. 

  • Aspen Pharmacare Holdings Limited

  • AstraZeneca PLC

  • B. Braun Melsungen AG

  • Baxter International Inc. 

  • Boehringer Ingelheim International GmbH 

  • Claris Lifesciences Limited

  • Eisai Co. Ltd.

  • F. Hoffmann-La Roche Ltd

  • Fresenius SE & Co. KGaA

  • Glenmark Pharmaceuticals Limited

  • Hikma Pharmaceuticals PLC

  • Hospira Inc

  • Maruishi Pharmaceutical Co. Ltd. 

  • Mylan NV

  • Pacira Pharmaceuticals Inc. 

  • Paion UK Ltd 

  • Pfizer Inc. 

  • Piramal Enterprises LTD 

  • Septodont Healthcare India Pvt. Ltd. 

  • Slayback Pharma LLC

  • Teva Pharmaceutical Industries Limited

  • Troikaa Pharmaceuticals Ltd.

 

 

Anesthesia Drugs Market by Info-graphics

 

Recent Development: -

  • On 13th July 2021, Hikma Pharmaceuticals PLC (Hikma), an international pharma company, launched Succiniylcholine Chloride Injection, USP 20mg/mL in the US, through its US affiliate, Hikma Pharmaceuticals USA Inc. In the treatment of COVID-19 patients Succinylcholine Chloride Injection, USP plays an important role. It is used to facilitate tracheal intubation as well as to relax skeletal muscles during a procedure or while on mechanical ventilation.

  • On 10th October 2016, Agreement to acquire Janssen’s injectable Anesthesia and pain management products by Critical Care in the UK a wholly-owned subsidiary of Piramal Enterprises.

Frequently Asked Question About This Report

b: North America has the highest market share of over 31.4% and the Asia Pacific is growing at the highest growth rate in the global market.

b: Major market participants include the following companies: Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG etc.

b: The anesthesia Drugs market is to grow at a CAGR of 3.47% between 2021 and 2028.

b: As of 2020, the market for anesthesia Drugs market size reached USD 6.8 Billion.

b: The key drivers of the market are the increasing ageing population around the globe, rising number of surgeries, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, moreover, the development of devices to monitor patient physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are driving factors that will boost the market growth.

b: On the basis of type, General anesthesia will dominate the Anesthesia Drugs market during the forecasted period.

Sources

https://m.economictimes.com/industry/healthcare/biotech/healthcare/covid-19-pandemic-will-lead-to-over-28-million-cancelled-surgeries-worldwide-study/articleshow/75757140.cms

https://www.plasticsurgery.org/news/press-releases/american-society-of-plastic-surgeons-predicts-new-industry-trends-amidst-covid19-reopenings